Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study

被引:587
作者
Khaw, Kay-Tee
Dowsett, Mitch
Folkerd, Elizabeth
Bingham, Sheila
Wareham, Nicholas
Luben, Robert
Welch, Ailsa
Day, Nicholas
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Sch Clin Med, Cambridge, England
[2] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England
[3] MRC, Dunn Human Nutr Unit, Cambridge, England
[4] MRC, Epidemiol Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
testosterone; hormones; epidemiology; men; mortality;
D O I
10.1161/CIRCULATIONAHA.107.719005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The relation between endogenous testosterone concentrations and health in men is controversial. Methods and Results - We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively (P < 0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone (approximate to 1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P < 0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years. Conclusions - In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.
引用
收藏
页码:2694 / 2701
页数:8
相关论文
共 48 条
[1]   Endogenous sex hormones and cardiovascular disease incidence in men [J].
Arnlov, Johan ;
Pencina, Michael J. ;
Amin, Shreyasee ;
Nam, Byung-Ho ;
Benjamin, Emelia J. ;
Murabito, Joanne M. ;
Wang, Thomas J. ;
Knapp, Philip E. ;
D'Agostino, Ralph B., Sr. ;
Bhasin, Shalendar ;
Vasan, Ramachandran S. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (03) :176-184
[2]   Drug therapy - Androgens in men - Uses and abuses [J].
Bagatell, CJ ;
Bremner, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :707-714
[3]   Editorial: Time for (more research on) testosterone [J].
Barrett-Connor, E ;
Bhasin, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :501-502
[4]   ENDOGENOUS SEX-HORMONES AND CARDIOVASCULAR-DISEASE IN MEN - A PROSPECTIVE POPULATION-BASED STUDY [J].
BARRETTCONNOR, E ;
KHAW, KT .
CIRCULATION, 1988, 78 (03) :539-545
[5]   USEFULNESS OF SEX STEROID-HORMONE LEVELS IN PREDICTING CORONARY-ARTERY DISEASE IN MEN [J].
CAULEY, JA ;
GUTAI, JP ;
KULLER, LH ;
DAI, WS .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (10) :771-777
[6]  
CONTOREGGI CS, 1990, J ANDROL, V11, P460
[7]  
Day N, 1999, BRIT J CANCER, V80, P95
[8]   Sex differences of endogenous sex hormones and risk of type 2 diabetes - A systematic review and meta-analysis [J].
Ding, EL ;
Song, YQ ;
Malik, VS ;
Liu, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (11) :1288-1299
[9]   Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies [J].
Eaton, NE ;
Reeves, GK ;
Appleby, PN ;
Key, TJ .
BRITISH JOURNAL OF CANCER, 1999, 80 (07) :930-934
[10]   Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study [J].
English, KM ;
Steeds, RP ;
Jones, TH ;
Diver, MJ ;
Channer, KS .
CIRCULATION, 2000, 102 (16) :1906-1911